跳至主要内容
临床试验/ISRCTN61052983
ISRCTN61052983进行中(未招募)4 期

EarLy extra Measles immunisation during a measles Outbreak

ational Institute for Public Health and the Environment0 个研究点目标入组 155 人开始时间: 2024年8月20日最近更新:
适应症

试验速览

阶段
4 期
状态
进行中(未招募)
发起方
入组人数
155

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Infants eligible for an MMR-0 immunisation and willing to receive the MMR-0 immunisation or having received the MMR-0 immunisation less than 4 weeks ago (MMR-0 group only)
  • 2. Infants willing to receive the MMR-1 immunisation at 14 months of age (control group)
  • 3. Infants have to be healthy according to the same health criteria applied in the well baby clinic when a child is immunised, e.g. also children with small increases in body temperature or a cold are seen as children with normal health
  • 4. The parents/legally representatives accept participation in the study according to the described procedures
  • 5. Presence of a signed informed consent (the parents/legally representatives have given written informed consent after receiving oral and written information)

排除标准

  • 1. Confirmed measles infection before study entry
  • 2. Having received an MMR immunisation (control group only)
  • 3. Contra-indications as mentioned in the SmPC of the vaccine, such as expected allergy or hypersensitivity against one of the vaccine ingredients.
  • 4. Receiving immunosuppressive medication
  • 5. Known or suspected immunological disorder
  • 6. Known or suspected bleeding disorder

研究者

发起方
ational Institute for Public Health and the Environment

相似试验

进行中(未招募)
1 期
EarLy extra Measles immunisation during a measles Outbreak (ELMO)Healthy infants receiving a profylactic vaccine to prevent measles infection
CTIS2024-513395-18-00Rijksinstituut voor Volksgezondheid en Milieu (RIVM)155
进行中(未招募)
1 期
MMR-3 research; The effect of a third vaccination with the mumps, measles and rubella combination vaccine on the immunity against the mumps virus in healthy young adults.immunological response to an extra mumps immunization (in healthy volunteers)
EUCTR2016-001104-36-NLRIVM147
尚未招募
不适用
Measuring and strengthening immunity to measles in young adults fully immunised in childhood - single arm challenge study
ACTRN12623000137695niversity of Otago100
尚未招募
不适用
Measuring and strengthening immunity to measles in young adults fully immunised in childhood - a randomised controlled trial (RCT)Waning measles immunity in vaccinated young adultsImmune healthPublic Health - Other public healthInflammatory and Immune System - Normal development and function of the immune system
ACTRN12623000130662niversity of Otago300
已完成
3 期
Intralesional measles, mumps, rubella (MMR) vaccine versus tuberculin purified protein derivative (PPD) in the treatment of palmoplantar and periungual warts: A randomized controlled trialClearance of wartswarts , tuberculin purified protein derivative (PPD), measles, mumps, rubella (MMR) vaccine , intralesional
TCTR20200604014Division of Dermatology, Department of medicine, Faculty of Medicine, Ramathibodi hospital40